Thrombosis Service

Active Research Projects

  • Novel Platelet Functions in Aging and Venous Thromboembolism (NIH Grant # AG1031065)
    • An NIH-funded bench-to-bedside investigation studying changes in platelet functions in aging and in patients at risk for venous thromboembolism (IRB_00026265).
  • Heparin Induced Thrombocytopenia Complicating Medically Ill Patients Receiving Pharmacological Prophylaxis: Prevalence, Management, and Outcomes. A Single Institution Retrospective Analysis (IRB_00015840)
    • A retrospective analysis of medically ill patients who develop heparin induced thrombocytopenia.
  • ADOPT: Apixaban Dosing to Optimize Protection from Thrombosis.  A study of medically ill deep vein thrombosis prevention using a novel oral Xa-inhibitor, apixaban (IRB_00024994).
  • RE-SONATE: Dabigatran etexilate in the long-term prevention of recurrent symptomatic venous thromboembolism in patients who have completed 6-18 months of treatment and are considering discontinuation of anticoagulation (IRB_00025795).
  • AMPLIFY: A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism (IRB_00029133).
  • BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery
  • FDG PET in Cancer Associated Venothromboembolism
    • An investigation to determine the sensitivity of FDG PET in the diagnosis of acute venothromboembolism and the value of FDG PET in early detection of occult cancer in this population (IRB_00018327).
  • Improving the Transition of Care from the Inpatient to Outpatient Setting in Patients Newly Started on Warfarin Therapy (IRB_00030733).
  • Prophylaxis against thrOmboembolism iniTiated in the Emergency department for high-risk medical patieNTs (POTENT): A National Quality Improvement Initiative for Hospitals, Begun in the ED (IRB_00029071).
  • Immunologic Mechanisms of Acute Lung Injury (IRB_00028210).
    • A translational investigation studying genetic influences and gene regulatory pathways on the influence of acute lung injury. This study is funded by a grant from the NIH.
  • Characterization of Novel Platelet Functions in Patients with Cancer (IRB_00026599).
    • A study to determine if pro-thrombotic pathways are upregulated and/or changed in patients with cancer, thus potentially increasing the risk of thromboembolic disease.
  • Novel Platelet Functions in Sepsis and Venous Thromboembolism (IRB_00029495).
    • A translational investigation studying novel platelet functions in patients with sepsis and correlating these activities with the risk of VTE. This study is funded by a grant from the NIH/CCTSA.
  • The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Events (Pfizer IIR_GA5951WK).
    • This study will determine if commonly-used antibiotics affect cellular activation and pro-thrombotic signaling events.